John R. Moore - 20 Sep 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
General Counsel
Signature
/s/ John R. Moore
Issuer symbol
EWTX
Transactions as of
20 Sep 2024
Transactions value $
-$1,946,220
Form type
4
Filing time
24 Sep 2024, 20:25:15
Previous filing
14 Aug 2024
Next filing
07 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Options Exercise $35.5K +50K +1537.52% $0.71 53.3K 20 Sep 2024 Direct
transaction EWTX Common Stock Sale -$1.42M -50K -93.89% $28.37 3.25K 20 Sep 2024 Direct
transaction EWTX Common Stock Options Exercise $14.9K +20.9K +643.36% $0.71 24.2K 23 Sep 2024 Direct
transaction EWTX Common Stock Sale -$578K -20.9K -86.55% $27.63 3.25K 23 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -50K -44.42% $0.00 62.6K 20 Sep 2024 Common Stock 50K $0.71 Direct F1
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -20.9K -33.44% $0.00 41.6K 23 Sep 2024 Common Stock 20.9K $0.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.